Japan, March 31 -- NEC Corporation announced that its FonesVisuas Test, an innovative blood test that predicts disease risk, is being offered by Royal Healthcare, a Singapore-based medical institution and group company of Sojitz Corporation that combines the latest medical expertise with the art of hospitality.According to the World Health Organization (WHO), the global rise in lifestyle-related diseases and dementia underscores the urgency for advanced predictive diagnostics. Concurrently, the Organisation for Economic Co-operation and Development (OECD) iLibrary data has identified cancer and cardiovascular diseases as leading causes of mortality worldwide, amplifying the urgency for proactive health management solutions.Royal Healthcare ...